Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRDN | RARE | RGC | ||
| Company | Viridian Therapeutics Inc | Ultragenyx Pharmaceu | Regencell Bioscience Holdings Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 23.23 | 27.16 | 5.33 | ||
| High | 23.83 | 27.59 | 5.36 | ||
| Low | 22.81 | 26.42 | 4.91 | ||
| Last | 22.97 | 26.96 | 5.02 | ||
| Change | -0.09 | +0.16 | -0.26 | ||
| Percent Change | -0.39% | +0.60% | -4.92% | ||
| Volume | 3,062,900 | 2,138,800 | 235,500 | ||
| 20-Day Average Volume | 1,960,535 | 2,004,190 | 232,100 | ||
| Previous | 23.06 | 26.80 | 5.28 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 20.09 | 27.00 | 5.61 | ||
| 20-Day Raw Stochastic | 86.33% | 37.39% | 22.77% | ||
| 20-Day Relative Strength | 66.74 | 48.29 | 31.24 | ||
| Weighted Alpha | +27.81 | +6.30 | -68.69 | ||
| Today's Opinion | 24% Buy | 24% Buy | 100% Sell | ||
| Yesterday's Opinion | 24% Buy | 24% Buy | 100% Sell | ||
| Last Month's Opinion | 40% Sell | 72% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.22% since 08/04/26 | +4.46% since 08/04/26 | -17.02% since 08/04/26 | ||
| Low | 20.53 on 08/06/26 | 24.60 on 08/05/26 | 4.91 on 08/11/26 | ||
| High | 23.83 on 08/11/26 | 28.48 on 08/05/26 | 6.23 on 08/05/26 | ||
| 1-Month | |||||
| %Chg | +16.36% since 07/10/26 | -20.28% since 07/10/26 | -14.63% since 07/10/26 | ||
| Low | 17.54 on 07/17/26 | 24.01 on 08/03/26 | 4.51 on 07/17/26 | ||
| High | 23.83 on 08/11/26 | 33.58 on 07/14/26 | 6.75 on 08/03/26 | ||
| 3-Month | |||||
| %Chg | +33.55% since 05/11/26 | +2.51% since 05/11/26 | -81.63% since 05/11/26 | ||
| Low | 15.50 on 06/10/26 | 21.33 on 06/02/26 | 4.51 on 07/17/26 | ||
| High | 23.83 on 08/11/26 | 36.57 on 07/07/26 | 30.00 on 05/15/26 | ||
| 6-Month | |||||
| %Chg | -23.61% since 02/11/26 | +12.90% since 02/11/26 | -81.21% since 02/11/26 | ||
| Low | 13.18 on 04/29/26 | 18.29 on 03/24/26 | 4.51 on 07/17/26 | ||
| High | 30.79 on 03/05/26 | 36.57 on 07/07/26 | 40.00 on 04/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,612,513 | 2,642,185 | 2,610,902 | ||
| Shares Outstanding, K | 113,292 | 98,589 | 494,489 | ||
| Annual Sales, $M | 70,850,000 | 673,000,000 | 0 | ||
| Annual Net Income, $M | -342,600,000 | -575,000,000 | -3,580,000 | ||
| Last Qtr Sales, $M | 280,000 | 214,000,000 | N/A | ||
| Last Qtr Income, $M | -127,120,000 | -92,000,000 | N/A | ||
| 60-Month Beta | 0.91 | 0.35 | 1.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.05 on 08/06/26 | -0.90 on 08/04/26 | N/A | ||
| Latest Earnings Date | 11/04/26 | 11/03/26 | 10/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | 02/15/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||